4.7 Review

Current knowledge and pharmacological profile of berberine: An update

Journal

EUROPEAN JOURNAL OF PHARMACOLOGY
Volume 761, Issue -, Pages 288-297

Publisher

ELSEVIER
DOI: 10.1016/j.ejphar.2015.05.068

Keywords

Berberine; Immunomodulation; Oxidative stress; Pharmacodynamics; Pharmacokinetics

Funding

  1. Council of Scientific and Industrial Research, New Delhi, India [09/135/705/2014-EMR-I]

Ask authors/readers for more resources

Berberine, a benzylisoquinoline alkaloid, occurs as an active constituent in numerous medicinal plants and has an array of pharmacological properties. It has been used in Ayurveclic and Chinese medicine for its antimicrobial, antiprotozoal, antidiarrheal and antitrachoma activity. Moreover, several clinical and preclinical studies demonstrate ameliorative effect of berberine against several disorders including metabolic, neurological and cardiological problems. This review provides a summary regarding the pharmacokinetic and pharmacodynamic features of berberine, with a focus on the different mechanisms underlying its multispectrum activity. Studies regarding the safety profile, drug interactions and important clinical trials of berberine have also been included. Clinical trials with respect to neurological disorders need to be undertaken to exploit the beneficiary effects of berberine against serious disorders such as Alzheimer's and Parkinson's disease. Also, clinical studies to detect rare adverse effects of berberine need to be initiated to draw a complete safety profile of berberine and strengthen its applicability. (C) 2015 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available